BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dawood M, Fleischer E, Klinger A, Bringmann G, Shan L, Efferth T. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344. Pharmacol Res 2020;160:105076. [PMID: 32659428 DOI: 10.1016/j.phrs.2020.105076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lu X, Yan G, Klauck SM, Fleischer E, Klinger A, Sugimoto Y, Shan L, Efferth T. Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK/eIF2α/ATF4 pathway. Biochem Pharmacol 2021;193:114788. [PMID: 34582772 DOI: 10.1016/j.bcp.2021.114788] [Reference Citation Analysis]
2 Liu W, Jin W, Zhu S, Chen Y, Liu B. Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis. Drug Discov Today 2021:S1359-6446(21)00450-5. [PMID: 34718209 DOI: 10.1016/j.drudis.2021.10.011] [Reference Citation Analysis]
3 Lu X, Yan G, Dawood M, Klauck SM, Sugimoto Y, Klinger A, Fleischer E, Shan L, Efferth T. A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells. Biochem Pharmacol 2021;:114677. [PMID: 34265280 DOI: 10.1016/j.bcp.2021.114677] [Cited by in F6Publishing: 1] [Reference Citation Analysis]